Comparing different adjuvants for HIV vaccines
Adjuvant Comparison and Characterization (HIV)
This study is looking at how different ingredients can make HIV vaccines work better by boosting the immune response, which could help create stronger and longer-lasting protection against HIV, especially in areas like the mouth and genitals, so that people can have better options for preventing the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11159357 on NIH RePORTER |
What this research studies
This research investigates how various adjuvants can enhance the effectiveness of HIV vaccines by comparing their ability to stimulate immune responses. The study aims to create detailed immunological profiles, known as 'immune fingerprints', to understand how these adjuvants work in different tissues. By focusing on the development of robust and long-lasting antibody responses, the research seeks to improve protection against HIV infections, particularly at mucosal sites. Patients may benefit from advancements in vaccine strategies that could lead to more effective prevention of HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of HIV infection who are interested in participating in vaccine trials.
Not a fit: Patients who are already living with HIV or those who are not at risk for HIV infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective HIV vaccines that provide better protection against the virus.
How similar studies have performed: Previous research has shown promise in enhancing vaccine responses through adjuvant use, indicating that this approach may lead to significant advancements in HIV vaccine development.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Pulendran, Bali — Stanford University
- Study coordinator: Pulendran, Bali
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.